CHRO — ChromoGenics AB Balance Sheet
0.000.00%
- SEK64.85m
- SEK85.06m
- SEK13.65m
Annual balance sheet for ChromoGenics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 24.9 | 93.4 | 18.9 | 24.1 | 7.93 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 15.8 | 7.75 | 13 | 9.29 | 6.48 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 50 | 111 | 45.7 | 46 | 29.8 |
| Net Property, Plant And Equipment | 74.3 | 90.8 | 102 | 103 | 98.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 132 | 214 | 160 | 162 | 139 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 41.7 | 29.6 | 52.6 | 24.9 | 27.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 89.4 | 92.9 | 103 | 91 | 96.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 42.6 | 121 | 57.7 | 70.5 | 42.8 |
| Total Liabilities & Shareholders' Equity | 132 | 214 | 160 | 162 | 139 |
| Total Common Shares Outstanding |